Table 5 Agreement (sensitivity, specificity) to predict patients vs control
| Â | AUC | p | 95% CI | Cutoff | Sensitivity (CI) | Specificity (CI) | PPV (CI) | NPV (CI) | |
|---|---|---|---|---|---|---|---|---|---|
L.L | U.L | ||||||||
miRNA | 0.996* | < 0.001* | 0.989 | 1.003 | > 1.61 | 100 (100–100) | 96 (88.3–100) | 96.2(94–100) | 100 (100–100) |
CA19.9 | 0.758* | < 0.001* | 0.650 | 0.866 | > 9.3 | 70.0(57.3–82.7) | 68.0 (49.7–86.3) | 81.4(69.7–93.0) | 53.1 (35.8–70.4) |
CEA | 0.628 | 0.073 | 0.491 | 0.765 | > 2.29 | 56 (42.3–69.7) | 52 (32.4–71.5) | 70 (55.8–77.3) | 37.1 (43.4–65.9) |